Jin Medical Starts New China Manufacturing Facility

Ticker: ZJYL · Form: 6-K · Filed: Oct 11, 2024 · CIK: 1837821

Jin Medical International Ltd. 6-K Filing Summary
FieldDetail
CompanyJin Medical International Ltd. (ZJYL)
Form Type6-K
Filed DateOct 11, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: manufacturing, expansion, china

TL;DR

JinMed is building a new factory in Chuzhou, China to boost production.

AI Summary

Jin Medical International Ltd. announced on October 10, 2024, the initiation of a new manufacturing facility in Chuzhou, China. This expansion is detailed in a press release attached to their Form 6-K filing.

Why It Matters

The establishment of a new manufacturing facility signifies potential for increased production capacity and market expansion for Jin Medical's orthopedic, prosthetic, and surgical supplies.

Risk Assessment

Risk Level: low — This filing is a routine report of a new facility initiation and does not contain significant financial or operational risks.

Key Players & Entities

  • Jin Medical International Ltd. (company) — Registrant
  • Chuzhou, China (location) — Location of new manufacturing facility
  • October 10, 2024 (date) — Date of press release

FAQ

What is the purpose of the new manufacturing facility in Chuzhou?

The filing states the initiation of a new manufacturing facility at Chuzhou, China, as announced in a press release on October 10, 2024.

When was the press release regarding the new facility issued?

The press release was issued on October 10, 2024.

What form is this filing?

This filing is a Form 6-K.

What is Jin Medical International Ltd.'s primary business according to the SIC code?

Jin Medical International Ltd.'s SIC code is 3842, which corresponds to Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Where is Jin Medical International Ltd.'s principal executive office located?

The principal executive office is located at No. 33 Lingxiang Road, Wujin District, Changzhou City, Jiangsu Province, People's Republic of China.

Filing Stats: 221 words · 1 min read · ~1 pages · Grade level 12 · Accepted 2024-10-11 16:10:22

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. JIN MEDICAL INTERNATIONAL LTD. Date: October 11, 2024 By: /s/ Erqi Wang Erqi Wang Chief Executive Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.